Clinical Trial

Efficacy and Safety of FEXUCLUE Tab. In Patients With Acute or Chronic Gastritis

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 17, 2025 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the efficacy of Fexuclue tablets in improving gastrointestinal symptoms based on patient-reported outcomes (PROs), by comparing assessments before and after treatment.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-21.
Status change: Not Yet Recruiting → Recruiting 2025-07-14
Trial Details
NCT Number NCT06948487
Lead Sponsor Daewoong Pharmaceutical Co. LTD.
Conditions Gastritis
Enrollment 12,000 participants
Start Date 2025-06-17
Primary Completion 2025-11-30 (estimated)
Study Completion 2027-06-03 (estimated)
Updated on ClinicalTrials.gov 2025-07-17